Brief: Relay Therapeutics Q3 Net Income USD -74.149 Million Vs. IBES Estimate USD -73.9 Million
06/11/2025 21:05
Nov 06 (Reuters) - Relay Therapeutics Q3 operating expenses USD 80.391 million. Q3 operating income USD -80.391 million Q3 basic EPS USD -0.43 Q3 EPS USD -0.43
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock